CRISPR Therapeutics AG (CRSP) Return on Sales (2016 - 2026)
CRISPR Therapeutics AG (CRSP) reported Return on Sales of 0.84% for Q1 2026, up 73.0% on a YoY basis from 0.49% in Q1 2025, and up 55.1% sequentially from 1.88% in Q4 2025.
CRISPR Therapeutics AG (CRSP) Return on Sales (2016 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 11 years of Return on Sales data on file, last reported at 0.84% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales rose 73.0% year-over-year to 0.84%; the trailing twelve-month figure through Mar 2026 stood at 1.46% (down 147.0% YoY), and the FY2025 full-year result was 1.75%, down 176.0% from the prior year.
- Return on Sales improved to 0.84% in Q1 2026, from 1.88% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.1% in Q4 2024 to a low of 184.29% in Q4 2022.
- A 5-year average of 13.56% and a median of 1.57% in 2025 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales tumbled 18418 bps in 2022 and surged 18430 bps in 2023, its largest moves.
- Tracing CRSP's Return on Sales over 5 years: stood at 184.29% in 2022, then soared by 100 bps to 0.0% in 2023, then soared by 2212 bps to 0.1% in 2024, then plunged by 1928 bps to 1.88% in 2025, then surged by 55 bps to 0.84% in 2026.
- Business Quant data shows CRSP's Return on Sales at 0.84% in Q1 2026, 1.88% in Q4 2025, and 1.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -0.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.84% |
| Dec 31, 2025 | -1.88% |
| Sep 30, 2025 | -1.20% |
| Jun 30, 2025 | -2.34% |
| Mar 31, 2025 | -1.57% |
| Dec 31, 2024 | 0.10% |
| Sep 30, 2024 | -1.43% |
| Jun 30, 2024 | -2.45% |
| Mar 31, 2024 | -2.31% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -184.29% |
| Sep 30, 2022 | -18.57% |
| Jun 30, 2022 | -11.76% |
| Mar 31, 2022 | -1.91% |
| Dec 31, 2021 | -0.11% |
| Sep 30, 2021 | -1.54% |
| Jun 30, 2021 | 0.01% |